FDA Inspection
AVEVA Drug Delivery Systems, Inc.AVEVA Drug Delivery Systems, Inc. – FDA Inspection, Sep 1, 2023
Record Details
This FDA Inspection record concerns AVEVA Drug Delivery Systems, Inc., with an inspection on September 1, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 77b02da3-cc98-4f5a-9942-991ed72d54d9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1216787
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.122(d)Label storage access limited to authorized personnel
- 21 CFR 211.52Washing and toilet facilities are deficient
- 21 CFR 211.122(d)Label storage access limited to authorized personnel
- 21 CFR 211.52Washing and toilet facilities are deficient
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AVEVA Drug Delivery Systems, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2026 | Not classified | Florida District Office | Drug Quality Assurance |
| July 26, 2019 | VAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| April 27, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 11, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 28, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AVEVA Drug Delivery Systems, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.